AIM ImmunoTech logo
AIM ImmunoTech AIM
€ 0.74 -14.24%

Quartalsbericht 2025-Q3
hinzugefügt 17.11.2025

report update icon

AIM ImmunoTech Langfristiger Schuldenstrom 2011-2026 | AIM

Langfristiger Schuldenstrom Jährlich AIM ImmunoTech

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
178 K 37 K 47 K 38 K 199 K - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
199 K 37 K 99.8 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Precigen Precigen
PGEN
1.14 M $ 3.1 -0.96 % $ 758 M usaUSA
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 220.9 2.49 % $ 5 B danmarkDanmark
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 19.57 1.77 % $ 915 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.33 0.76 % $ 339 M britainBritain
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
1.54 M $ 1.58 6.04 % $ 99.5 M niderlandNiderland
Cara Therapeutics Cara Therapeutics
CARA
1.92 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
203 K - -74.18 % $ 955 K usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
1.63 M $ 8.31 1.59 % $ 111 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
18.6 M $ 47.09 1.42 % $ 4.23 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
547 K $ 4.53 5.1 % $ 868 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
4.24 M $ 4.22 -0.47 % $ 582 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA